Listen to experts report on current publications, posters, and sessions from a recent rheumatology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Updates on Current Treatment Options for RA-ILD
Launched: June 12, 2020

New Treatment Options for SSc-ILD
Launched: June 12, 2020
 

 

 
 

Therapies on the Horizon for RA-ILD
Launched: June 12, 2020

New Directions in the Diagnosis of RA-ILD
Launched: June 12, 2020

 

 
 

Monitoring for Changes in Disease Course and Comorbidities in SSc-ILD
Launched: June 12, 2020

Download Audio